Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Monoglyceride lipase (Homo sapiens (Human)) | BDBM50582221 (CHEMBL5090028 | US11708359, Example 60) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | 0.00700 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2JM2FRS | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311805 (7-(4-Fluorophenyl)-8-(7-chloro-1H-indazol-5-yl)-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0100 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288255 (7-Chloro-5-(2-isopropyl-6-(trifluoromethyl)pyrazol...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0100 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288248 (5-(2,6-Bis(trifluoromethyl)pyrazolo[1,5-a]pyridin-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0130 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288254 (5-(2-Isopropyl-6-(trifluoromethyl)pyrazolo[1,5-a]p...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0130 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288253 (5-(2-Isopropyl-6-(trifluoromethyl)pyrazolo[1,5-a]p...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0160 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288247 (5-(2,6-Bis(trifluoromethyl)pyrazolo[1,5-a]pyridin-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0160 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288245 (5-(2,6-Bis(trifluoromethyl)pyrazolo[1,5-a]pyridin-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0160 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311771 (2-Cyclopentyl-7-(4-fluorophenyl)-8-(7-methyl-1H-in...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0160 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288302 (7-(7-Chloro-1H-indazol-5-yl)-6-(difluoromethyl)-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0160 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288246 (5-(2,6-Bis(trifluoromethyl)pyrazolo[1,5-a]pyridin-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0160 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Monoglyceride lipase (Homo sapiens (Human)) | BDBM609871 ((rac)-(2s,4s)-2-(6-(4-(tert-Butyl)phenyl)-3-azabic...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | 0.0190 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2JM2FRS | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292056 (2-Cyclobutyl-3-(7-methyl-1H-indazol-5-yl)-5-(trifl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0200 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292057 (3-(7-Chloro-1H-indazol-5-yl)-2-cyclobutyl-5-(trifl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0200 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288250 (5-(2-Cyclopropyl-6-(trifluoromethyl)pyrazolo[1,5-a...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0200 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Monoglyceride lipase (Homo sapiens (Human)) | BDBM50582222 (CHEMBL5074982 | US11708359, Example 71) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | 0.0240 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2JM2FRS | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311766 (2-Cyclobutyl-7-(4-fluorophenyl)-8-(7-methyl-1H-ind...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0250 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288303 (6-(Difluoromethyl)-7-(7-methyl-1H-indazol-5-yl)-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0250 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311848 (8-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-7-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0250 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311806 (7-(4-Fluorophenyl)-8-(7-methyl-1H-indazol-5-yl)-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0320 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311808 (2-(Difluoromethyl)-7-(4-fluorophenyl)-8-(7-methyl-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0320 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292055 (7-Chloro-5-(2-cyclobutyl-5-(trifluoromethyl)-2H-py...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0320 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311811 (7-Isopropyl-8-(7-methyl-1H-indazol-5-yl)-2-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0320 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Monoglyceride lipase (Homo sapiens (Human)) | BDBM609880 ((rac)-(2s,4s)-2-(6-(4-(1-Methylcyclopropyl)phenyl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | 0.0340 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2JM2FRS | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288237 (6-(4-Fluorophenyl)-5-(7-methyl-1H-indazol-5-yl)-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0400 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311847 (5-(2,7-Bis(trifluoromethyl)imidazo[1,2-a]pyridin-8...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288301 (5-[6-(Difluoromethyl)-2-(trifluoromethyl)pyrazolo[...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288304 (5-[6-(Difluoromethyl)-4-methyl-2-(trifluoromethyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288251 (5-(2-Cyclopropyl-6-(trifluoromethyl)pyrazolo[1,5-a...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288235 (5-(7-Chloro-1H-indazol-5-yl)-6-(1,1-difluoroethyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288249 (5-(2-Cyclopropyl-6-(trifluoromethyl)pyrazolo[1,5-a...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292054 (5-(2-Cyclobutyl-5-(trifluoromethyl)-2H-pyrazolo[4,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288252 (7-Chloro-5-(2-cyclopropyl-6-(trifluoromethyl)pyraz...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0630 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292053 (3-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-5-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0630 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288252 (7-Chloro-5-(2-cyclopropyl-6-(trifluoromethyl)pyraz...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0630 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288239 (5-(6-(4-Fluorophenyl)-2-(trifluoromethyl)-[1,2,4]t...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0630 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288189 (5-(7-Chloro-1H-indazol-5-yl)-2-(difluoromethyl)-6-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0630 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Monoglyceride lipase (Homo sapiens (Human)) | BDBM609878 ((rac)-(2s,4s)-2-(6-(3-Chloro-4-methylphenyl)-3- az...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | 0.0750 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2JM2FRS | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288256 (5-(2-Isopropyl-6-(trifluoromethyl)pyrazolo[1,5-a]p...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0790 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288183 (5-(7-Chloro-1H-indazol-5-yl)-2,6-bis(trifluorometh...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0790 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288218 (5-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-6-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0790 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311810 (2-Cyclopropyl-7-(4-fluorophenyl)-8-(7-methyl-1H-in...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0790 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311768 (7-Cyclopentyl-8-(7-methyl-1H-indazol-5-yl)-2-(trif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0790 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Monoglyceride lipase (Homo sapiens (Human)) | BDBM630876 ((7-((3,6-Dimethyl-5-(trifluoromethyl)pyridin-2-yl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311849 (2-Isopropyl-8-(7-methyl-1H-indazol-5-yl)-7-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311828 (8-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-7-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288224 (5-(7-Chloro-1H-indazol-5-yl)-2-(1,1-difluoroethyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288307 (7-(7-Chloro-1H-indazol-5-yl)-6-(difluoromethyl)-4-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292061 (5-(Difluoromethyl)-2-isopropyl-3-(7-methyl-1H-inda...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel gamma-8 subunit (Homo sapiens (Human)) | BDBM288198 (5-(7-Chloro-1H-indazol-5-yl)-6-(difluoromethyl)-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description This assay was used to test compounds for their ability to inhibit TARP γ8 dependent AMPA receptor activity. The AMPA receptor is a non-selectiv... | US Patent US10087185 (2018) BindingDB Entry DOI: 10.7270/Q2QZ2D0H | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 1399 total ) | Next | Last >> |